BioSpace News Archive

FDA Approves EndoClot ® Hemostat to Manage GI Bleeding A Unique Product to Rapidly and Reliably Control Bleeding During GI Procedures

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced that Brian M. Culley, Chief Executive Officer, will be presenting at the Raymond James 42nd Annual Institutional Investors conference on March 1, 2021 at 11:40am Eastern Time / 8:40am Pacific Time.

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced it has partnered with Amplity Health in connection with the anticipated U.S. launch of Brexafemme (ibrexafungerp)

Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter and year ended December 31, 2020, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook for 2021.

Symposiums will demonstrate clinical utility and introduce practitioners to pupillometry and NPi as a valuable measurement in managing patients at risk of brain injury

BrainsWay Ltd., a global leader in the advanced noninvasive treatment of brain disorders, announced it has priced an underwritten public offering of 4,622,000 American Depositary Shares, each representing two ordinary shares, at an offering price of $8.50 per American Depositary Share.

Availability of superior surgical procedures like cosmetic surgery, dental surgery, orthopedic and cardiovascular surgery will drive the global medical tourism market growth.

Rising adoption of immunoprecipitation technique along with intensifying proteomics and genomics research is expected to boost magnetic beads market growth.

Growing geriatric population base along with increasing cases of organ failure are expected to be some of the growth rendering factors for medical biomimetics market.

Growing utilization of medical X-ray machine to detect numerous health conditions such as bone fractures, infections, calcifications, tumors, arthritis, and others will augment medical X-ray market growth in the upcoming years.